Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Migraine therapy].

Literature DB >> 15995849

[Migraine therapy].

Abstract

With more than 8 million sufferers in Germany alone, migraine is one of the most frequent medical disorders. Recent discoveries in the pathophysiology and genetics of headaches, as well as specific developments in pharmacology, have paved the way for a significant improvement in both acute migraine treatment and migraine prevention. Within the group of 5-HT(1B/D)-agonists (triptans), seven substances with 23 dosages and formulations have been approved in Germany that allow the customized treatment of migraine attacks. In addition, several new drugs such as valproic acid or topiramate are now available as drugs of first choice for migraine prevention, as well as the well established beta blockers, thus enabling the physician to tailor the preventative treatment according to the individual needs of the patient.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2005 PMID： 15995849 DOI： 10.1007/s00108-005-1459-9

Source DB: PubMed Journal: Internist (Berl) ISSN： 0020-9554 Impact factor: 0.743

25 in total

1. Medication overuse is more than just taking too much.

Authors: H-C Diener
Journal: Cephalalgia Date: 2005-07 Impact factor: 6.292

2. Double-blind randomized placebo-controlled study of homoeopathic prophylaxis of migraine.

Authors: T E Whitmarsh; D M Coleston-Shields; T J Steiner
Journal: Cephalalgia Date: 1997-08 Impact factor: 6.292

3. Classical homeopathic treatment of chronic headaches.

Authors: H Walach; W Haeusler; T Lowes; D Mussbach; U Schamell; W Springer; G Stritzl; W Gaus; G Haag
Journal: Cephalalgia Date: 1997-04 Impact factor: 6.292

4. Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults?

Authors: M L Hämäläinen; K Hoppu; P Santavuori
Journal: Neurology Date: 1997-04 Impact factor: 9.910

5. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials.

Authors: R B Lipton; W F Stewart; R E Ryan; J Saper; S Silberstein; F Sheftell
Journal: Arch Neurol Date: 1998-02

6. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study.

Authors: Paul Winner; Donald Lewis; W Hester Visser; Kaihong Jiang; Suzanne Ahrens; Judith K Evans
Journal: Headache Date: 2002-01 Impact factor: 5.887

Review 7. Acetylsalicylic acid in the treatment of headache.

Authors: V Limmroth; Z Katsarava; H C Diener
Journal: Cephalalgia Date: 1999-07 Impact factor: 6.292

8. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.

Authors:
Journal: Cephalalgia Date: 1999-05 Impact factor: 6.292

Review 9. Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine.

Authors: David Dodick; Richard B Lipton; Vincent Martin; Vasilios Papademetriou; Wayne Rosamond; Antoinette MaassenVanDenBrink; Hassan Loutfi; K Michael Welch; Peter J Goadsby; Steven Hahn; Susan Hutchinson; David Matchar; Stephen Silberstein; Timothy R Smith; R Allan Purdy; Jane Saiers
Journal: Headache Date: 2004-05 Impact factor: 5.887